Table 2.
Distribution of exposure and covariables of interest across participating studies.
| Exposure and covariables of interest | INUENDO-Greenland | INUENDO-Ukraine | PCB cohort | HUMIS | DNBC | FETOTOXa | INMA-Valencia | INMA-Sabadell | INMA-Gipuzkoa |
|---|---|---|---|---|---|---|---|---|---|
| () | () | () | () | () | () | () | () | () | |
| Measured PFOS concentrations {ng/mL [median (range)]}a | 20.19 (4.1–87.3) | 5.01 (0.8–18.1) | 0.03 (0.0–0.7) | 0.11 (0.0–0.5) | 33.55 (6.4–106.7) | 26.90 (3.9–103.8) | 6.20 (0.8–18.5) | 6.39 (0.3–38.6) | 5.30 (1.2–17.5) |
| Measured PFOA concentrations {ng/mL [median (range)]}b | 1.83 (0.5–5.1) | 0.96 (0.2–9.8) | 0.03 (0.0–0.2) | 0.04 (0.0–0.2) | 5.26 (0.5–41.5) | 4.00 (0.5–17.7) | 2.39 (0.3–10.1) | 2.87 (0.3–31.6) | 1.66 (0.4–8.1) |
| Child sex (% male) | 53.5 | 52.8 | 43.2 | 54.2 | 50.3 | 80.4 | 51.8 | 51.9 | 50.2 |
| Child birth weight [kg ()] | |||||||||
| Maternal educational level (%) | |||||||||
| Low | 56.8 | 60.6 | 46.5 | 8.4 | 2.6 | 4.6 | 26.1 | 23.7 | 10.2 |
| Medium | 41.7 | 39.4 | 50.3 | 13.7 | 30.5 | 37.4 | 45.0 | 44.4 | 37.2 |
| High | 1.5 | 0.0 | 3.2 | 77.9 | 66.9 | 58.0 | 28.8 | 31.9 | 52.7 |
| Maternal age at delivery [y ()] | |||||||||
| Maternal prepregnancy BMI [ ()] | |||||||||
| Prenatal maternal smoking (% smokers)c | 87.4 | 31.0 | 17.6 | 7.8 | 20.8 | 28.6 | 39.1 | 26.7 | 22.7 |
| Parity (% nulliparous) | 31.9 | 80.0 | 36.8 | 37.8 | 45.1 | 47.5 | 57.4 | 59.0 | 55.5 |
| Duration of total breastfeeding [months ()] | |||||||||
| Sample time from birth [months ()] | |||||||||
Note: BMI, body mass index; DNBC, Danish National Birth Cohort; HUMIS, Norwegian Human Milk Study; INMA, Infancia y Medio Ambiente; PCB, polychorinated biphenyl; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonate; SD, standard deviation.
Observations in FETOTOX were selected using case–cohort sampling.
PFAS concentrations were measured in maternal serum/plasma in INUENDO-Greenland, INUENDO-Ukraine, DNBC, FETOTOX, INMA-Valencia, INMA-Sabadell, and INMA-Gipuzkoa and in breast milk in HUMIS and the PCB cohort. Specific details on chemical-analytical methods and detection/quantification limits in each study are included in Table S1.
In INUENDO maternal smoking was assessed prior to pregnancy.